Serum S100B Levels in Patients after Cardiac Surgery: Possible Sources of Contamination

Abstract

Background: S100B protein is considered to be a potential marker of brain damage. The aim of our study was to determine the contamination effect of retransfused blood on the serum S100B concentrations in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to differentiate between this simple contamination effect and its possible enhancement by haemolysis. Methods: The first part of the study was performed in a group of 10 patients scheduled for coronary artery bypass grafting. Baseline S100B level was determined in a blood sample drawn from the radial artery before skin incision. After performing the distal anastomosis, additional blood samples were drawn from 1) the radial artery, 2) the aortic root catheter, 3) the pericardial space, and 4) CPB suction. To study the possible haemolytic effect on serum S100B levels, a second group of 23 patients was studied. S100B concentrations were determined in samples drawn simultaneously from the radial artery and bypass circuit after the end of CPB. Further samples from the retransfusion blood bag were analysed after one, two and three hours. Results: Blood samples from the pericardial space and CPB suction exhibited significantly higher levels of S100B than the samples drawn from the peripheral artery and aortic root catheter in the first group of patients. No significant differences between the S100B levels in the peripheral blood and aortic root catheter were detected. In the second group, S100B was significantly elevated in the samples taken from the retransfusion blood bag in comparison with peripheral blood. S100B levels remained stable during the whole follow-up period. Conclusion: The results of our study show increased serum S100B levels caused by contamination originating in the mediastinal tissues. Storage of blood in the retransfusion bag and haemolysis can be excluded as sources of contamination. The role of S100B in perioperative monitoring of patients undergoing cardiac surgery remains to be established and should be confirmed by further studies using neuropsychological tests and imaging techniques.

cardiovascular surgery - heart disease - coronary bypass surgery

References

• 1 Mahanna E P, Blumenthal J A, White W D, Croughwell N D, Clancy C P, Smith L R, Newman M F. Defining neuropsychological dysfunction after coronary artery bypass grafting.  Ann Thorac Surg. 1996;  61 1342-1347
• 2 Babin-Ebell J, Misoph M, Müllges W, Neukam K, Reese J, Elert O. Intraoperative embolus formation during cardiopulmonary bypass affects the release of S100B.  Thorac Cardiovasc Surg. 1999;  47 166-169
• 3 Shaaban Ali M, Harmer M, Kirkham F. Cardiopulmonary bypass temperature and brain function.  Anaesthesia. 2005;  60 365-372
• 4 Sylivris S, Levi C, Matalanis G, Rosalion A, Buxton B F, Mitchell A, Fitt G, Harberts D B, Saling M M, Tonkin A M. Pattern and significance of cerebral micro-emboli during coronary artery bypass grafting.  Ann Thorac Surg. 1998;  66 1674-1678
• 5 Taylor K M. Central nervous system effects of cardiopulmonary bypass.  Ann Thorac Surg. 1998;  66 (Suppl 5) S20-S24
• 6 Herrmann M, Ebert A D, Galazky I, Wunderlich M T, Kunz W S, Huth C. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue.  Stroke. 2000;  31 645-650
• 7 Jönsson H, Johnsson P, Alling C, Bäckström M, Bergh C, Blomquist S. S100β after coronary artery surgery: release pattern, source of contamination and relation to neuropsychological outcome.  Ann Thorac Surg. 1999;  68 2202-2208
• 8 Kanbak M, Saricaoglu F, Avci A, Ocal T, Koray Z, Aypar U. Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: a preliminary study of S-100beta protein levels.  Can J Anaesth. 2004;  51 712-717
• 9 Kilminster S, Treasure T, McMillan T, Holt D W. Neuropsychological change and S‐100 protein release in 130 unselected patients undergoing cardiac surgery.  Stroke. 1999;  30 1869-1874
• 10 Akbari H M, Whitaker-Azmitia P M, Azmitia E C. Prenatal cocaine decreases the trophic factor S‐100 beta and induced microcephaly: reversal by postnatal 5-HTIA receptor agonist.  Neurosci Letters. 1994;  170 141-144
• 11 Jönsson H, Johnsson P, Bäckström M, Alling C, Dautovic-Bergh C, Blomquist S. Controversial significance of early S100B levels after cardiac surgery.  BMC Neurology. 2004;  4 24
• 12 Zimmer D B, Cornwall E H, Landar A, Song W. The S100 protein family: history, function, and expression.  Brain Res Bull. 1995;  37 417-429
• 13 Diegeler A, Hirsch R, Schneider F, Schilling L O, Falk V, Rauch T, Mohr F W. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation.  Ann Thorac Surg. 2000;  69 1162-1166
• 14 Abraha H, Butterworth R, Bath P, Wassif W, Gartwhaite J, Sherwood R. Serum S‐100 protein, relationship to clinical outcome in acute stroke.  Ann Clin Biochem. 1997;  34 366-370
• 15 Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S‐100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.  Stroke. 1997;  28 1961-1965
• 16 Missler U, Wiesmann M, Friedrich C, Kaps M. S‐100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.  Stroke. 1997;  28 1956-1960
• 17 Johnsson P, Backstrom M, Bergh C, Jonsson H, Luhrs C, Alling C. Increased S100B in blood after cardiac surgery is a powerful predictor of late mortality.  Ann Thorac Surg. 2003;  75 162-168
• 18 Motallebzadeh R, Kanagasabay R, Bland M, Kaski J C, Jahangiri M. S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery.  Eur J Cardiothorac Surg. 2004;  25 409-414
• 19 Taggart D P, Bhattacharya K, Meston N, Standing S J, Kay J D, Pillai R, Johnssson P, Westaby S. Serum S100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration.  Eur J Cardiothorac Surg. 1997;  11 645-649
• 20 Jönsson H, Johnsson P, Birch-Iensen M, Alling C, Westaby S, Blomquist S. S100B as a predictor of size and outcome of stroke after cardiac surgery.  Ann Thorac Surg. 2001;  71 1433-1437
• 21 Tseng E E, Brock M V, Lange M S, Blue M E, Troncoso J C, Kwon C C, Lowenstein C J, Johnston M V, Baumgartner W A. Neuronal nitric oxide synthase inhibition reduces neuronal apoptosis after hypothermic circulatory arrest.  Ann Thorac Surg. 1997;  64 1639-1647
• 22 Blomquist S, Johnsson P, Luhrs C, Malmkvist G, Solem J O, Alling C, Stahl E. The appearance of S‐100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury.  J Cardiothorac Vasc Anesth. 1997;  11 699-703
• 23 Georgiadis D, Berger A, Kowatschev E, Lautenschlager C, Borner A, Lindner A, Schulte-Mattler W, Zerkowski H R, Zierz S, Deufel T. Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery.  J Thorac Cardiovasc Surg. 2000;  119 138-147
• 24 Westaby S, Saatvedt K, White S, Katsumata T, van Oeveren W, Halligan P W. Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass?.  Ann Thorac Surg. 2001;  71 667-672
• 25 Barbut D, Lo Y W, Gold J P, Trifiletti R R, Yao F S, Hager D N, Hinton R B, Isom O W. Impact of embolization during coronary artery bypass grafting on outcome and length of stay.  Ann Thorac Surg. 1997;  63 998-1002
• 26 Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning.  Stroke. 1994;  25 1393-1399
• 27 Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response.  Ann Thorac Surg. 2004;  78 54-59
• 28 Anderson R E, Hansson L O, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass.  Ann Thorac Surg. 2000;  69 847-850
• 29 Anderson R E, Hansson L O, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources.  Ann Thorac Surg. 2001;  71 1512-1517
• 30 Ishida K, Gohara T, Kawata R, Ohtake K, Morimoto Y, Sakabe T. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?.  J Cardiothorac Vasc Anesth. 2003;  17 4-9
• 31 Oki A, Ohtake H, Okada Y, Kawada T, Takaba T. Simultaneous monitoring of somatosensory evoked potentials and regional cerebral oxygen saturation combined with serial measurement of plasma levels of cerebral specific proteins for the early diagnosis of postoperative brain damage in cardiovascular surgery.  J Artif Organs. 2004;  7 13-18
• 32 Rasmussen L S, Christiansen M, Eliasen K, Sander-Jensen K, Moller J T. Biochemical markers for brain damage after cardiac surgery - time profile and correlation with cognitive dysfunction.  Acta Anaesthesiol Scand. 2002;  46 547-551
• 33 Svenmarker S, Engstrom K G, Karlsson T, Jansson E, Lindholm R, Aberg T. Influence of pericardial suction blood on memory function and release of protein S100B.  Perfusion. 2004;  19 337-343
• 34 Fazio V, Bhudia S K, Marchi N, Aumayr B, Janigro D. Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring?.  Ann Thorac Surg. 2004;  78 46-52
• 35 Mielck F, Ziarkowski A, Hanekop G, Armstrong V W, Hilgers R, Weyland A, Quintel M, Sonntag H. Cerebral inflammatory response during and after cardiac surgery.  Eur J Anaesthesiol. 2005;  22 347-352